The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Motilium Fastmelts 10mg Orodispersible Tablets

Johnson & Johnson (Ireland) LimitedPA0330/040/001

Main Information

Trade NameMotilium Fastmelts 10mg Orodispersible Tablets
Active SubstancesDomperidone
Dosage FormOrodispersible tablet
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/040/001

Group Information

ATC CodeA03FA Propulsives
A03FA03 domperidone


License statusAuthorised
Licence Issued11/01/2008
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceFor non-prescription, pharmacy-only sale: MS 10 mg; MDD: 30 mg; MPS: 10: MQP: 100 mg. Pack sizes containing more than 10 tablets are subject to prescription.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back